Physician profile
Bennett Chotiner
NPI 1346210044
$1,652.37
in general payments reported to CMS, 2019-2025
16 companies · $462 in 2025
The $462 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $166 · 2022: $297 · 2023: $109 · 2024: $371 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $941.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $941.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $400.76 | 2022-2025 | Clareon, Clareon Panoptix Pro |
| Johnson & Johnson Surgical Vision, INC. | $208.59 | 2024-2025 | Tecnis Iol |
| Galderma Laboratories, L.P. | $150.00 | 2020 | |
| Sun Pharmaceutical Industries INC. | $141.55 | 2019-2025 | |
| Abbvie INC. | $136.37 | 2023-2025 | Ozurdex, Durysta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $124.86 | 2019 | |
| Kala Pharmaceuticals, INC. | $123.10 | 2022 | |
| Carl Zeiss Meditec USA, INC. | $102.66 | 2024 | Cirrus Hd-Oct |
| Lilly USA, LLC | $95.70 | 2019 | |
| Carl Zeiss Meditec, INC. | $60.00 | 2022 | |
| Rxsight INC | $35.72 | 2023 | Rxsight Injector Cartridge, Rxsight Light Adjustable Lens (Rxlal), Rxsight Light Delivery Device (Ldd) |
| Bausch & Lomb Americas INC. | $17.64 | 2022 | |
| Aerie Pharmaceuticals, INC. | $16.00 | 2020 | |
| Sight Sciences, INC. | $15.75 | 2022 | |
| Allergan, INC. | $12.64 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $11.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bennett Chotiner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.